Device Knees

Persona Partial Knee System

Payments companies reported to CMS as associated with Persona Partial Knee System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.1Massociated payments (2023-2025)
66clinicians with associated payments
1company reporting

By year

2023 $1,761
2024 $971K
2025 $172K

Payments reported as associated with Persona Partial Knee System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $835K
Adult Reconstructive Orthopaedic Surgery $310K
Physician Assistant $131
Surgical $46.64
Sports Medicine (Orthopaedic Surgery) $19.82
Pediatric Orthopaedic Surgery $19.82

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Persona Partial Knee System

These are the largest totals companies reported as associated with Persona Partial Knee System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Richard Williamson Mount Vernon, WA Orthopaedic Surgery $226,645.73
Craig Della Valle Chicago, IL Adult Reconstructive Orthopaedic Surgery $226,645.73
Richard Moore Boise, ID Orthopaedic Surgery $219,641.01
Lindsey Rolston New Castle, IN Orthopaedic Surgery $219,641.01
Brad Penenberg Beverly Hills, CA Orthopaedic Surgery $82,525.92
John Masonis Charlotte, NC Orthopaedic Surgery $82,525.92
Scott Sporer Winfield, IL Adult Reconstructive Orthopaedic Surgery $82,525.92
Jeffrey Milles Columbia, MO Adult Reconstructive Orthopaedic Surgery $421.50
Matthew Mangini Cincinnati, OH Adult Reconstructive Orthopaedic Surgery $393.12
Joseph Scheidler Hamilton, OH Orthopaedic Surgery $391.21

Prescribed Persona Partial Knee System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.